Bank Of America Corp Valneva Se Transaction History

Bank Of America Corp

  • $1.33 Trillion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$10.38 - $14.87 $13,213 - $18,929
-1,273 Reduced 4.85%
25,000 $318,000
Q3 2022

Nov 14, 2022
BUY
$9.8 - $23.35 $12,475 - $29,724
1,273 Added 5.09%
26,273 $265,000
Q1 2022

May 16, 2022
BUY
$27.0 - $50.99 $675,000 - $1.27 Million
25,000 New
25,000 $858,000

Others Institutions Holding VALN

# of Institutions
19
Shares Held
4.51M
Call Options Held
0
Put Options Held
0
View Full List

About Valneva SE

VALN Quotes by TradingView
  • Ticker VALN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,103,504
  • Market Cap $650M
  • Description
  • Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...
More about VALN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email